GEP19981392B - N,n-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1h-indol-3-yl) ethylamine, indole derivatives and physiologically acceptable salts and solvates thereof, methods of preparing thereof, drug for treatment or prophylaxes of clinical states for which administration of 5-ht1-like receptor agonist, and method of preparing thereof - Google Patents
N,n-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1h-indol-3-yl) ethylamine, indole derivatives and physiologically acceptable salts and solvates thereof, methods of preparing thereof, drug for treatment or prophylaxes of clinical states for which administration of 5-ht1-like receptor agonist, and method of preparing thereofInfo
- Publication number
- GEP19981392B GEP19981392B GEAP19931112A GEAP1993001112A GEP19981392B GE P19981392 B GEP19981392 B GE P19981392B GE AP19931112 A GEAP19931112 A GE AP19931112A GE AP1993001112 A GEAP1993001112 A GE AP1993001112A GE P19981392 B GEP19981392 B GE P19981392B
- Authority
- GE
- Georgia
- Prior art keywords
- preparing
- drug
- indole derivatives
- oxazolidin
- indol
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 5
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 229940054051 antipsychotic indole derivative Drugs 0.000 title abstract 3
- 150000002475 indoles Chemical class 0.000 title abstract 3
- 239000000018 receptor agonist Substances 0.000 title abstract 2
- 229940044601 receptor agonist Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title 1
- 239000012453 solvate Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 231100001231 less toxic Toxicity 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909012672A GB9012672D0 (en) | 1990-06-07 | 1990-06-07 | Therapeutic heterocyclic compounds |
| PCT/GB1991/000908 WO1991018897A1 (en) | 1990-06-07 | 1991-06-06 | Therapeutic heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP19981392B true GEP19981392B (en) | 1998-11-10 |
Family
ID=10677193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP19931112A GEP19981392B (en) | 1990-06-07 | 1993-07-22 | N,n-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1h-indol-3-yl) ethylamine, indole derivatives and physiologically acceptable salts and solvates thereof, methods of preparing thereof, drug for treatment or prophylaxes of clinical states for which administration of 5-ht1-like receptor agonist, and method of preparing thereof |
Country Status (7)
| Country | Link |
|---|---|
| GB (1) | GB9012672D0 (enExample) |
| GE (1) | GEP19981392B (enExample) |
| RU (1) | RU2110517C1 (enExample) |
| SA (1) | SA91120058B1 (enExample) |
| SG (1) | SG52664A1 (enExample) |
| TW (1) | TW223072B (enExample) |
| ZA (1) | ZA914340B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9516145D0 (en) * | 1995-08-07 | 1995-10-04 | Wellcome Found | Improved chemical synthesis |
| GB9928578D0 (en) * | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Pharmaceutical formulations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8600398D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
-
1990
- 1990-06-07 GB GB909012672A patent/GB9012672D0/en active Pending
-
1991
- 1991-06-05 TW TW80104430A patent/TW223072B/zh not_active IP Right Cessation
- 1991-06-06 SG SG1996007538A patent/SG52664A1/en unknown
- 1991-06-06 ZA ZA914340A patent/ZA914340B/xx unknown
- 1991-06-06 RU SU5011473/04A patent/RU2110517C1/ru active
- 1991-08-05 SA SA91120058A patent/SA91120058B1/ar unknown
-
1993
- 1993-07-22 GE GEAP19931112A patent/GEP19981392B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG52664A1 (en) | 1998-09-28 |
| ZA914340B (en) | 1993-02-24 |
| TW223072B (enExample) | 1994-05-01 |
| SA91120058B1 (ar) | 2005-11-30 |
| GB9012672D0 (en) | 1990-08-01 |
| RU2110517C1 (ru) | 1998-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU91555I2 (fr) | "Brinzolamide et timolol optionnellement sous de sels pharmaceutiquement acceptables te que la combination du produit brinzolamide/timolol maléate (AZARGA)" | |
| BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
| IL103798A (en) | Indole derivatives pharmaceutical compositions containing them and intermediates for their preparation | |
| GEP20043324B (en) | Purine Derivatives | |
| IL81349A0 (en) | Vinylphenol derivatives,their preparation and pharmaceutical compositions containing them | |
| TNSN99191A1 (fr) | Derives d'adenine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| IL101162A (en) | Pharmaceutical composition for oral administration comprising an indole derivative | |
| AU2458392A (en) | Novel medical use for tachykinin antagonists | |
| NO166448C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner. | |
| RU94022479A (ru) | Применение антиэстрогенных соединений, а также фармацевтически приемлемых солей и сольватов для уменьшения концентрации глюкозы в крови, фармацевтический препарат | |
| GR3006091T3 (enExample) | ||
| DK122391D0 (da) | Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme | |
| MY124465A (en) | Reduction of infarct volume using citicoline | |
| GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
| GEP19981392B (en) | N,n-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1h-indol-3-yl) ethylamine, indole derivatives and physiologically acceptable salts and solvates thereof, methods of preparing thereof, drug for treatment or prophylaxes of clinical states for which administration of 5-ht1-like receptor agonist, and method of preparing thereof | |
| NO950177D0 (no) | Farmakologisk aktive erivater | |
| ATE219378T1 (de) | Esramustine formulierungen mit verbesserten eigenschaften | |
| JO1653B1 (en) | The current benzimidazole is a therapeutically active method for preparing it | |
| BR0005039A (pt) | Antagonistas do receptor nk-1 e eletriptano para o tratamento da enxaqueca |